Literature DB >> 22413513

[Antidiabetic fixed-dose combination tablet for the management of type 2 diabetes].

Naoki Sakane1.   

Abstract

How to use oral antidiabetic fixed-dose combination tablet for the management of type 2 diabetes (T2DM)? In addition to diet and exercise, the majority of diabetic patients need drug therapy to achieve optimal glycemic control. Monotherapy with oral antidiabetic agent is the firstline pharmacologic treatment option. However, in order to maintain glycemic control, additional oral antidiabetic agents are often added to monotherapies resulting in dual therapy. Dual therapy can be prescribed as separate pills, or as a single pill containing two agents. Randomized controlled trials of patients requiring dual therapy, have shown fixed-dose combination therapies to have superior efficacy when compared to loose-pills combination therapies. T2DM patients treated with fixed-dose combination therapies may have better adherence, improved satisfaction, and lower direct costs, compared to those treated with loose-pill combination therapies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22413513

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  1 in total

1.  Pharmacokinetics of a fixed-dose combination of mitiglinide and metformin versus concurrent administration of individual formulations in healthy subjects: a randomized, open-label, two-treatment, two-period, two-sequence, single-dose, crossover study.

Authors:  Jin Ah Jung; Jung-Ryul Kim; Suk-Ran Kim; Tae-Eun Kim; Soo-Youn Lee; Jae-Wook Ko; Wooseong Huh
Journal:  Clin Drug Investig       Date:  2012-12       Impact factor: 2.859

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.